{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-006421","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2026-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.787181+00:00","generated_at":"2026-05-16T11:22:30.523919+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Crinetics prices $350M common stock offering at $45.95/share to fund PALSONIFY launch","bullets":["Pricing: 7,620,000 shares at $45.95/share; gross proceeds ~$350M.","Underwriters granted 30-day option to buy up to 1,143,000 additional shares.","Net proceeds expected ~$330.2M, or ~$379.8M if option exercised.","Proceeds to fund commercial launch of PALSONIFY, R&D, and general corporate purposes.","Offering expected to close January 8, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-006421","json":"https://secwatch.observer/filing/0001193125-26-006421.json","markdown":"https://secwatch.observer/filing/0001193125-26-006421.md","text":"https://secwatch.observer/filing/0001193125-26-006421.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000119312526006421/0001193125-26-006421-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000119312526006421/d22132d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:22:30.523919+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}